How to Prepare Biochemistry for FMGE 2026: High-Yield Topics and Strategy
By Dr. Utsav Bhattacherjee, MBBS, MBA · 25 August 2026 · 9 min read
Biochemistry has a reputation for feeling abstract next to the clinical subjects, but FMGE tests it in a very applied way — diagnostic enzyme panels, vitamin deficiency presentations, and metabolic disorders you will actually encounter in practice. The mechanisms you learned for their own sake in the pre-clinical years come back here as clinical reasoning tools.
FMGE Biochemistry high yield topics
- Vitamin deficiency disorders — the clinical presentation tied to each specific vitamin, not just the biochemical role.
- Diagnostic enzymes — which enzyme elevation points to which organ system, a staple of lab-interpretation questions.
- Core metabolic pathways — glycolysis, the TCA cycle, the urea cycle and gluconeogenesis, tested through their regulatory steps and the clinical consequences of a blockage.
- Inborn errors of metabolism — a defined set of genetic enzyme deficiencies, each with a characteristic clinical picture.
- Lipid and lipoprotein metabolism — dyslipidaemia patterns and the enzymes governing them.
- Molecular biology fundamentals — DNA replication, mutation types and PCR, tested more as applied lab-medicine concepts than pure molecular theory.
Vitamin deficiency disorders worth memorising cold
| Vitamin | Deficiency disorder | Key clinical feature |
|---|---|---|
| B1 (Thiamine) | Beriberi, Wernicke-Korsakoff syndrome | Peripheral neuropathy, high-output cardiac failure, confusion and ataxia |
| B2 (Riboflavin) | Ariboflavinosis | Angular stomatitis, cheilosis, glossitis |
| B3 (Niacin) | Pellagra | Dermatitis, diarrhoea, dementia — the classic triad |
| B6 (Pyridoxine) | Peripheral neuropathy | Seen classically with isoniazid use, which depletes B6 |
| B9 (Folate) | Megaloblastic anaemia | No neurological involvement — the key distinction from B12 |
| B12 (Cobalamin) | Megaloblastic anaemia with neurological involvement | Subacute combined degeneration of the spinal cord |
| C (Ascorbic acid) | Scurvy | Bleeding gums, poor wound healing, corkscrew hairs |
| D | Rickets (children), osteomalacia (adults) | Defective bone mineralisation |
| K | Bleeding diathesis | Prolonged PT — a cofactor for clotting factors II, VII, IX and X |
The B12-versus-folate distinction is worth calling out specifically: both cause an identical-looking megaloblastic anaemia, but only B12 deficiency produces neurological findings, since folate is not involved in the myelin synthesis pathway B12 supports.
Diagnostic enzymes: matching enzyme to organ
Lab-interpretation questions reward knowing which enzyme elevation localises to which organ system, rather than treating elevated enzymes as one undifferentiated finding:
- AST and ALT — liver injury, with ALT considered more liver-specific than AST.
- Alkaline phosphatase (ALP) — bone or biliary pathology; pairing it with GGT helps localise further, since GGT rises with biliary causes but not with bone-source ALP elevation.
- CK-MB and troponin — cardiac muscle injury, with troponin now the more specific and widely used marker.
- Amylase and lipase — pancreatic injury, with lipase considered more specific to the pancreas than amylase.
- GGT — biliary tract pathology, and a sensitive marker of alcohol use.
Inborn errors of metabolism
These are a defined, learnable set rather than an open-ended list, and each pairs a specific enzyme deficiency with a characteristic clinical picture:
- Phenylketonuria (PKU) — phenylalanine hydroxylase deficiency, leading to intellectual disability if untreated, with a classic musty odour to urine and sweat.
- Maple syrup urine disease — a defect in branched-chain amino acid metabolism, producing the characteristic sweet, maple-syrup-smelling urine.
- Alkaptonuria — homogentisate oxidase deficiency, causing urine that darkens on standing and, over time, ochronosis (dark pigmentation of connective tissue).
- Von Gierke disease (glycogen storage disease type I) — glucose-6-phosphatase deficiency, producing severe fasting hypoglycaemia alongside hepatomegaly.
Each of these has a signature clinical detail — the odour, the urine colour change, the specific pattern of hypoglycaemia — that functions as a fast recognition cue in a vignette, rather than requiring you to work backward from the full biochemical pathway under time pressure.
Core metabolic pathways: focus on the regulatory steps and the blocks
Rather than memorising every intermediate in glycolysis, the TCA cycle or the urea cycle, prioritise two things: the rate-limiting regulatory enzymes, and what happens clinically when a specific step is blocked. A block in the urea cycle, for instance, causes ammonia accumulation with a specific clinical picture regardless of which exact enzyme in the cycle is deficient — recognising the pattern of hyperammonaemia is often more exam-relevant than reciting the full cycle from memory.
Lipid metabolism: the dyslipidaemia pattern worth knowing
Rather than memorising every step of lipoprotein synthesis and transport, focus on the clinically testable pattern: LDL carries cholesterol to tissues and is the target of statin therapy; HDL carries cholesterol back to the liver and is generally protective at higher levels; and triglycerides are carried primarily by chylomicrons and VLDL. Familial hypercholesterolaemia — a defect in the LDL receptor — is the single most commonly referenced genetic dyslipidaemia, presenting with markedly elevated LDL, premature atherosclerosis, and physical signs like tendon xanthomas and corneal arcus at a young age. Statins work by inhibiting HMG-CoA reductase, the rate-limiting enzyme in cholesterol synthesis — a mechanism worth knowing cold, since it connects the biochemistry directly to a drug class you will prescribe regularly in practice.
Molecular biology fundamentals: applied, not theoretical
FMGE tends to test molecular biology as it applies to lab medicine and genetics rather than as pure theory. A few concepts worth prioritising:
- Mutation types — a point mutation changes a single base; a frameshift mutation (an insertion or deletion not in multiples of three) shifts the entire reading frame downstream, typically producing a more severe effect than a single point mutation.
- PCR (polymerase chain reaction) — understand it as a tool for amplifying a specific DNA sequence, which is why it underlies most modern genetic and infectious disease diagnostic testing you will encounter clinically.
- DNA replication direction — replication proceeds 5 prime to 3 prime, which is why the lagging strand is synthesised discontinuously as Okazaki fragments while the leading strand is synthesised continuously — a detail that shows up in questions testing the mechanics rather than just the end result.
Treating these as tools you will actually use to interpret clinical genetic testing, rather than isolated molecular biology trivia, makes them easier to retain and faster to recall under exam conditions.
A smart study plan for FMGE Biochemistry
- Build your vitamin and enzyme tables early, since they function as fast-recall tools across nearly every other clinical subject too — Biochemistry knowledge here directly supports Medicine and Paediatrics questions.
- Anchor metabolic pathways to their clinical blockage consequences rather than memorising the pathway as an isolated diagram — that is the form the exam actually tests it in.
- Treat inborn errors of metabolism as a fixed, learnable list rather than an intimidating open category — there are a defined handful that repeat, each with one or two signature clues.
- Revisit this subject in your final review pass, since its high density of memorisable, pattern-based facts holds up well under compressed, late-stage revision.
Diagnostic-pattern recall like this is exactly what pays off under real exam time pressure. For the complete high-yield picture across every FMGE subject, see our FMGE high yield topics guide, and for how this fits into your overall timeline, our FMGE December 2026 preparation strategy covers the sequencing across subjects.
